Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate
- 31 July 1993
- Vol. 42 (1) , 13-20
- https://doi.org/10.1016/0090-4295(93)90325-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapyRadiotherapy and Oncology, 1992
- Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation TherapyJournal of Urology, 1991
- Prostate Specific Antigen Levels after Definitive Irradiation for Carcinoma of the ProstateJournal of Urology, 1991
- Prostate-Specific Antigen and External Beam Radiation Therapy in Prostate CancerCancer, 1991
- Prostate Specific Antigen and Local Recurrence after Radical ProstatectomyJournal of Urology, 1990
- Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, 1989
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radiation Treated PatientsJournal of Urology, 1989
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated PatientsJournal of Urology, 1989
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- The Role of Routine Followup Bone Scans After Definitive Therapy of Localized Prostatic CancerJournal of Urology, 1982